Thursday 15 June 2017

The Brewery, London EC1



London branch:
150 Cheapside
London EC2V 6ET


Stifel is a US-incorporated, NYSE-listed institutional wealth manager and investment bank, focused on the middle market. It provides strategic advisory services to its clients in North America, Europe and Asia that include initiating, structuring and negotiating mergers, acquisitions and divestitures, as well as providing fairness opinions, valuation, and restructuring services. It raises equity and public and private debt for its clients through its institutional and retail brokerage network. Stifel has a strategic emphasis globally on the healthcare sector, with senior bankers focused across all products, based in Europe and North America.


Consilium Strategic Communications Ltd
41 Lothbury
Tel: +44 (0) 20 3709 5700

Consilium Strategic Communications

Consilium Strategic Communications is an international advisory firm specialising in healthcare strategic communications. From offices in Europe and across the US, Consilium's highly skilled team provides long-term advice to healthcare companies, boards, senior decision makers and executives on critical communications programmes, investor relations and stakeholder challenges.


Phil Walker
Director Healthcare Corporate Finance
Tel: +44 (0) 203 829 5583

Dr Gary Waanders
Director Healthcare Research
Tel: +44 (0) 203 829 5617

Dominic Wilson
Director Healthcare Sales
Tel: +44 (0) 203 829 5618

Zeus Capital

Zeus Capital is an independent investment banking boutique, providing the highest quality advice to clients across a range of sectors and transactions. Our expertise enables us to guide companies through the often complex process of making acquisitions, selling a business, management buy outs/ins and IPOs. Zeus has helped raise over £2.5bn for clients in the last three years. In 2016 it raised 28% of funds for corporate IPOs on AIM. Zeus now acts as broker and/or financial adviser/nominated adviser to 27 corporate clients with a combined market cap of £7.3bn.

Zeus Capital’s Healthcare team has a wealth of experience managing transactions coupled with broking and research relationships that give a real insight into value drivers in the healthcare sector. The Healthcare team has advised on healthcare transactions raising a gross value of almost £375m since the beginning of 2014.


To contact one of our offices: 

Bavariaring 26
80336 München, Germany
Phone +49-89-210228-0

Kaiser-Friedrich-Ring 5
40545 Düsseldorf, Germany
Phone +49-211-529252-0

Or email us at:

MC Services AG 

MC Services AG is an international public relations and investor relations firm specialising in communications for the life sciences and healthcare sectors. A strong team of science, finance, media and communication experts with extensive industry experience positions MC Services as the leading life sciences agency in Europe. MC Services' long-standing clients include international public and private companies as well as venture capitalists and investment firms. Established for many years as a link between the healthcare industry and the financial markets, MC Services provides comprehensive services in investor relations, public relations and financial transactions. MC Services is based in Munich, Düsseldorf, London and Boston.


Instinctif Partners provides a full service communications consultancy focused on science-based sectors.

65 Gresham Street
Tel: +44 (0) 20 7457 2020
Fax: +44 (0) 20 74866 7900

Instinctif Partners 

Instinctif Partners is an international business communications consultancy. Over three decades we have built a track record of delivering strategic counsel and insightful and creative programmes, focused on enhancing the value proposition for companies seeking investment, partnerships or customers. Our core skill is working with clients to communicate the value of their science and innovation to key stakeholders through the most relevant channels: crafting communications solutions that showcase each company, product or technology. Specifically, we are unique in offering specialist expertise seamlessly across corporate, financial, healthcare and marketing communications with outreach programmes to media, industry, professional, public, financial and investment communities. Headquartered in London, our globally integrated and dedicated life sciences team serves clients around the world from our bases in the EU, the US and Asia Pacific.


RBC Capital Markets is a premier global investment bank providing expertise in banking, finance and capital markets.

RBC Capital Markets  

RBC Capital Markets is a premier global investment bank providing expertise in banking, finance and capital markets to corporations, institutional investors, asset managers and Governments around the world. We serve clients from 70 offices in 15 countries across North America, the UK, Europe and the Asia Pacific region.  Our more than 7,400 professionals deliver the experience and insights required to raise capital, access markets, mitigate risk and acquire or dispose of assets for clients worldwide. We are consistently ranked, by third-party sources, among the ten largest and most significant investment banks globally.

The Global Healthcare Group provides clients with deep industry expertise delivered through an integrated, global investment and corporate banking team.  We have a dedicated team of over 40 professionals providing a full range of financing and advisory services. Our industry knowledge, combined with outstanding client service and execution, has resulted in recurring transactions for our clients as they successfully migrate through each stage of growth.

RBC Capital Markets is part of a leading, diversified provider of financial services, Royal Bank of Canada (RBC). Operating since 1869, RBC is one of the largest banks in the world and the fifth largest in North America, as measured by market capitalisation. With a strong capital base and consistent financial performance, RBC is among a small group of highly rated global banks.


Shore Capital Markets, a division
of Shore Capital Group, is an independent securities business with a large and extensive research and sales capability offering comprehensive distribution to institutions and mid and small cap companies.

Bidhi Bhoma
Director, Investment
Banking - Healthcare
Tel: +44 (0)20 7468 7904

Dr Tara Raveendran
Healthcare Research
Tel: +44 (0)20 7647 8142

Shore Capital 

Shore Capital Markets, a division of Shore Capital Group, is an independent securities business with a large and extensive research and sales capability offering comprehensive distribution to institutions and mid and small-cap companies. This distribution capability is complemented by Shore Capital’s experienced corporate finance and broking team who are dedicated to offering innovative and valued advice to London-listed companies on both the Main Market and AIM. Shore Capital is also one of the largest market makers in the London market. Shore Capital Markets has been involved in transactions raising more than £4.6bn in equity capital markets since January 2014.

Shore Capital’s Healthcare team provides comprehensive research coverage across the entire UK healthcare spectrum. This includes major pharma, specialty pharma, medical devices, life sciences and healthcare services. Our research product provides our clients with detailed, insightful analysis, with a particular focus on in-depth, high quality research. Healthcare research is distributed to over 300 UK and European institutions via our highly experienced sales people, including two healthcare specialists.


Panmure is a corporate and institutional stockbroker and investment bank.

Panmure Gordon & Co
One New Change
Tel: +44 (0)20 7886 2500 


Panmure Gordon

Panmure Gordon is a leading independent stockbroker and investment bank specialising in corporate advice, M&A and institutional investment for the UK’s most ambitious and successful companies. Our deep healthcare knowledge and expertise has assisted clients to IPO, raise development capital and complete successful M&A transactions.

Our clients value our breadth of sector knowledge, track record and tailored, integrated service that is relationship led and outcome driven.


Peel Hunt is an independent, full-service specialist broking and advisory house, focused on UK mid and small caps, with a leading Healthcare and Life Sciences franchise.

Moor House
120 London Wall
London EC2Y 5ET
Tel: +44 (0) 20 7418 8900
Fax: +44 (0) 20 7418 8848

Peel Hunt 

Peel Hunt is an independent, full-service specialist broking and advisory house with a focus on UK mid and small-cap companies. Our partnership structure, over 25 years of profitability, extensive trading platform and focus on long-term client relationships set us apart from our peers. We have expertise across a broad range of sectors and seek to offer high quality advice, ideas-led research and flawless execution within a team-based and collegiate environment. Peel Hunt benefits from a powerful distribution platform and since 2015 we have completed over 100 ECM transactions (including 23 IPOs). We have over 115 retained corporate clients and continue to grow strongly.

Our Healthcare and Life Sciences team comprises dedicated sector specialists across research, sales and corporate with unparalleled access to small, mid and larger-cap investors across the UK, Europe and North America. In recent years Peel Hunt has raised over £1bn for its healthcare clients and we represent companies in the sector with an aggregate market capitalisation of over £4bn.

Peel Hunt LLP is authorised and regulated by the Financial Conduct Authority.


60 Gresham Street, 4th Floor
London, EC2V 7BB

Tel: +44 (0) 20 3861 6625
Fax: +44 (0) 20 7600 5975

Northland Capital Partners

Northland Capital Partners is a leading independent institutional stockbroker and corporate finance adviser. We provide broking and advisory services to quoted growth companies and facilitate access to capital.
Driven by our broad network of investors, and wide expertise in the consumer, technology, natural resources and healthcare sectors, our team has established a proven track record in raising funds for clients. We pride ourselves on a solutions-driven approach that allows our clients to achieve their growth ambitions.


7 Ensign House, Admirals Way
London, E14 9XQ

Tel: +44 (0)20 7536 2000

Design Portfolio

For over 25 years Design Portfolio has been helping quoted companies communicate effectively and efficiently. We consult with and support a wide variety of corporate clients from FTSE 100 to AIM, as well as private companies and those new to market. Sectors in which we can demonstrate specialist knowledge include life sciences, healthcare, medtech and biotech. 

We work in print, digital and moving image across six core areas: 

  • Annual reports 
  • Investor presentations 
  • Corporate websites 
  • Video and animation 
  • Sustainability communications 
  • Corporate branding 

Our blend of considered creativity and expert consultancy is delivered by expert teams through a local, personal and hands-on service with offices in London, Leeds, Cambridge, Edinburgh and Miami. 

 Supported by: 



BioCentury Main Office
1235 Radio Road, Ste. 100
Redwood City, CA 94065-1217
Tel: +1 650-595-5333
Tel: +1 650-595-5589




Since 1993, BioCentury Inc. has been internationally recognised as the leading provider of value-added information, analysis and data for biotechnology and pharmaceutical companies, investors, academia and Government on the strategic issues essential to the formation, development and sustainability of life science ventures.

BioCentury employs a fully integrated multimedia platform – including publications, online data solutions, conferences and eLearning programmes – to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.

The company publishes the weekly editions of its flagship publication, BioCentury®, and BioCentury Week in Review, plus daily editions of BioCentury Extra. BioCentury also publishes BioCentury Innovations, a weekly translational science journal.

The company also markets BCIQ, the industry's premiere business intelligence and research database. It provides easy access to data on thousands of companies and products and $400+bn in financings.


LSP is one of the world's largest specialised healthcare and biotechnology investment firms.

Johannes Vermeerplein 9 
1071 DV Amsterdam 
Tel: +31 (0) 20 664 5500 
Fax: +31 (0) 20 676 8810


With offices in Amsterdam, Munich and Boston, LSP has successfully invested in the healthcare and biotechnology sectors for over two decades. Since its inception in the late 80s, LSP has invested in a large number of both privately held and publicly traded life science companies, many of which have become leaders in their respective industries.


Cambridge (Head Office)
The Portway
Granta Park
CB21 6GS
Tel: +44 (0) 1223 896 450
Fax: +44 (0) 1223 896 471

One Nucleus 

One Nucleus is an international membership organisation for life science and healthcare companies. We are based in Cambridge with the majority of our members across the Cambridge/London corridor – at the heart of Europe’s largest life science and healthcare cluster. We have over 470 organisations as members, including pharmaceutical, biotech, medical device and diagnostic companies and associated technical and commercial service providers.

One Nucleus’ mission is to maximise the global competitiveness of our members. For our science and technology-based members, that means them being global leaders in the research, development and commercialisation of healthcare innovations that radically improve the quality of people’s lives around the world. For our business and professional services members, it means them delivering exceptional services that significantly enhance the business performance of their clients.
Collectively, the membership forms a commercial, clinical and academic powerhouse. Around 80% of our members are based in the Cambridge/London corridor, an area which is home to at least 60% of the UK’s life science industry base.

With our critical mass of membership (being the largest in Europe by some way), as well as the services we offer, the member benefits include:
  • A large and significant pool of companies to support business-to-business interaction within the membership.
  • Membership of a cluster of international size, relevance and visibility.
  • Major impact both in the UK and overseas with the compelling excellence of our members articulated strongly to international organisations, institutions and Governments for ultimate member benefit.